HRT Financial’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-16,524
| Closed | -$510K | – | 2039 |
|
2024
Q1 | $510K | Buy |
+16,524
| New | +$510K | ﹤0.01% | 1188 |
|
2023
Q4 | – | Sell |
-37,211
| Closed | -$981K | – | 2141 |
|
2023
Q3 | $981K | Buy |
+37,211
| New | +$981K | 0.01% | 896 |
|
2023
Q2 | – | Sell |
-162,406
| Closed | -$2.69M | – | 2269 |
|
2023
Q1 | $2.69M | Buy |
162,406
+56,770
| +54% | +$941K | 0.03% | 444 |
|
2022
Q4 | $804K | Buy |
105,636
+10,488
| +11% | +$79.8K | 0.01% | 1017 |
|
2022
Q3 | $945K | Buy |
95,148
+77,921
| +452% | +$774K | 0.01% | 930 |
|
2022
Q2 | $156K | Buy |
+17,227
| New | +$156K | ﹤0.01% | 2253 |
|
2022
Q1 | – | Sell |
-53,138
| Closed | -$886K | – | 2815 |
|
2021
Q4 | $886K | Sell |
53,138
-191,518
| -78% | -$3.19M | 0.01% | 1090 |
|
2021
Q3 | $11.5M | Buy |
+244,656
| New | +$11.5M | 0.07% | 123 |
|